{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T19:40:17Z","timestamp":1735760417550,"version":"3.32.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.rmed.2022.107071","type":"journal-article","created":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T01:26:07Z","timestamp":1670376367000},"page":"107071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Etiology of pulmonary hypertension in multiple myeloma: A case series and literature review"],"prefix":"10.1016","volume":"206","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1375-4779","authenticated-orcid":false,"given":"Taylor","family":"Desmarais","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4844-8715","authenticated-orcid":false,"given":"Jenny","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Narezkina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rmed.2022.107071_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin."},{"key":"10.1016\/j.rmed.2022.107071_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2013.10.029","article-title":"Updated clinical classification of pulmonary hypertension","author":"Simonneau","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"43","key":"10.1016\/j.rmed.2022.107071_bib3","article-title":"Clinical impact of echocardiography-defined pulmonary hypertension on the clinical outcome in patients with multiple myeloma","volume":"99","author":"Bae","year":"2020","journal-title":"Medicine (Baltim.)"},{"issue":"5","key":"10.1016\/j.rmed.2022.107071_bib4","article-title":"Echocardiography-defined pulmonary hypertension in multiple myeloma: risk factors and impact on outcomes","volume":"109","author":"Sangani","year":"2016","journal-title":"SMA"},{"issue":"2","key":"10.1016\/j.rmed.2022.107071_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.117.003973","article-title":"Increasing incidence and prevalence of WHO groups 1-4 pulmonary hypertension: a population-based cohort study in ontario, Canada","volume":"11","author":"Wijeratne","year":"2018","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.rmed.2022.107071_bib6","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1086\/682430","article-title":"Pulmonary hypertension complicating multiple myeloma","volume":"5","author":"Krishnan","year":"2015","journal-title":"Pulm. Circ."},{"issue":"4","key":"10.1016\/j.rmed.2022.107071_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211049300","article-title":"Carfilzomib-associated pulmonary arterial hypertension in multiple myeloma","volume":"11","author":"Yang","year":"2021","journal-title":"Pulm. Circ."},{"issue":"3","key":"10.1016\/j.rmed.2022.107071_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0031-1273085","article-title":"Multiple myeloma, venous thromboembolism, and treatment-related risk of thrombosis","volume":"37","author":"Zamagni","year":"2011","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.rmed.2022.107071_bib9","doi-asserted-by":"crossref","unstructured":"McGee M, Whitehead N, Martin J, Collins N. Drug-associated pulmonary arterial hypertension. Clin. Toxicol., 56:9, 801-809, DOI: 10.1080\/15563650.2018.1447119.","DOI":"10.1080\/15563650.2018.1447119"},{"issue":"1","key":"10.1016\/j.rmed.2022.107071_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00217-2017","article-title":"Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study","volume":"50","author":"Weatherald","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.rmed.2022.107071_bib11","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1513\/AnnalsATS.202008-913OC","article-title":"Association between leflunomide and pulmonary hypertension","volume":"18","author":"Palasset","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.rmed.2022.107071_bib12","first-page":"A6790","article-title":"Carfilzomib-induced pulmonary hypertension: a rare complication with reversal after discontinuation","volume":"199","author":"Hrustranovic-Kadic","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"volume":"vol. 2022","year":"2022","author":"Alexander","key":"10.1016\/j.rmed.2022.107071_bib13"},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2022.107071_bib14","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Martinez-Naharro","year":"2018","journal-title":"Clin. Med."},{"issue":"2","key":"10.1016\/j.rmed.2022.107071_bib15","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"issue":"16","key":"10.1016\/j.rmed.2022.107071_bib16","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.rmed.2022.107071_bib17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","article-title":"Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989","volume":"79","author":"Kyle","year":"1992","journal-title":"Blood"},{"issue":"Issue 9","key":"10.1016\/j.rmed.2022.107071_bib18","article-title":"Pulmonary hypertension in HFpEF and HFrEF: JACC review topic of the week","volume":"76","author":"Guazzi","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl 35","key":"10.1016\/j.rmed.2022.107071_bib19","doi-asserted-by":"crossref","first-page":"S4296","DOI":"10.21037\/jtd.2018.09.87","article-title":"Cardiovascular adverse events in multiple myeloma patients","author":"Heckmann","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.rmed.2022.107071_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/1752-1947-2-229","article-title":"Multiple myeloma presenting with high-output heart failure and improving with anti-angiogenesis therapy: two case reports and a review of the literature","volume":"2","author":"Robin","year":"2008","journal-title":"J. Med. Case Rep."},{"issue":"11","key":"10.1016\/j.rmed.2022.107071_bib22","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1158\/1078-0432.CCR-07-4153","article-title":"Involvement of hepcidin in the anemia of multiple myeloma","volume":"14","author":"Sharma","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"18","key":"10.1016\/j.rmed.2022.107071_bib23","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2010-03-274571","article-title":"In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2","volume":"116","author":"Maes","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rmed.2022.107071_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0002-9343(90)90092-R","article-title":"Presence and clinical characteristics of high cardiac output state in patients with multiple myeloma","volume":"89","author":"McBride","year":"1990","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.rmed.2022.107071_bib25","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/rth2.12411","article-title":"Venous thromboembolism in multiple myeloma is associated with increased mortality","volume":"4","author":"Schoen","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rmed.2022.107071_bib26","doi-asserted-by":"crossref","first-page":"e02","DOI":"10.15420\/icr.2020.14","article-title":"Balloon pulmonary angioplasty: state of the art","volume":"16","author":"Coghlan","year":"2021","journal-title":"Intervent Cardiol."},{"issue":"1","key":"10.1016\/j.rmed.2022.107071_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1470-2045(15)00464-7","article-title":"ENDEAVOR Investigators. Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study","volume":"17","author":"Dimopoulos","year":"2016","journal-title":"Lancet Oncol."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122003365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611122003365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T19:04:52Z","timestamp":1735758292000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611122003365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":26,"alternative-id":["S0954611122003365"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2022.107071","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Etiology of pulmonary hypertension in multiple myeloma: A case series and literature review","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2022.107071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107071"}}